First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, Amir Hossein Daneshmanesh et al.|Leukemia|2018Cited by 52
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinibAmir Hossein Daneshmanesh, Håkan Mellstedt, Mohammad Hojjat‐Farsangi et al.|PLoS ONE|2018Cited by 43
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma CellsAmineh Ghaderi, Mohammad Hojjat‐Farsangi, Georgios Z. Rassidakis et al.|Biomedicines|2020Cited by 38
Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lungWalter Wang, David P. Carbone, Konstantin Shilo et al.|Cell Death and Disease|2021Cited by 22
A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) CellsAmineh Ghaderi, Håkan Mellstedt, Wen Zhong et al.|Pharmaceutics|2022Cited by 19